T1D Exchange published research in Diabetes Technology & Therapeutics using NorstellaLinQ lab data linked to their T1D patient registry and wearable device data. The objective of the study was to evaluate the prevalence of cardiovascular, renal, and hepatic biomarkers that fall outside guideline-based thresholds in adults with type 1 diabetes, and to identify demographic and clinical factors associated with these biomarkers.
